Previous Article | Next Article 
The Journal of Neuroscience, July 1, 1999, 19(13):5195-5204
A Zinc-Dependent Cl
Current in Neuronal Somata
Toshihide
Tabata and
Andrew T.
Ishida
Section of Neurobiology, Physiology, and Behavior, University of
California, Davis, California 95616-8519
 |
ABSTRACT |
Extracellular Zn2+ modulates current passage
through voltage- and neurotransmitter-gated ion channels, at
concentrations less than, or near, those produced by release at certain
synapses. Electrophysiological effects of cytoplasmic
Zn2+ are less well understood, and effects have been
observed at concentrations that are orders of magnitude greater than
those found in resting and stimulated neurons. To examine whether and
how neurons are affected by lower levels of cytoplasmic
Zn2+, we tested the effect of
Zn2+-selective chelators,
Zn2+-preferring ionophores, and exogenous
Zn2+ on neuronal somata during whole-cell
patch-clamp recordings. We report here that cytoplasmic zinc
facilitates the downward regulation of a background
Cl
conductance by an endogenous protein kinase C
(PKC) in fish retinal ganglion cell somata and that this regulation is
maintained if nanomolar levels of free Zn2+ are
available. This regulation has not been described previously in any
tissue, as other Cl
currents have been described
as reduced by PKC alone, reduced by Zn2+ alone, or
reduced by both independently. Moreover, control of cation currents by
a zinc-dependent PKC has not been reported previously. The regulation
we have observed thus provides the first electrophysiological
measurements consistent with biochemical measurements of zinc-dependent
PKC activity in other systems. These results suggest that contributions
of background Cl
conductances to electrical
properties of neurons are susceptible to modulation.
Key words:
background chloride conductance; resting potential; outward rectification; PKC; Zn2+; divalent
cation
 |
INTRODUCTION |
Calcium, magnesium, and zinc are
found in both bound and ionized forms in neuronal and muscle cytoplasm.
Of these, the concentration and physiological effects of unbound
intracellular calcium (Ca2+) have been studied most
extensively. Fluorescent indicators and patch-clamp methods have shown
substantial agreement between the endogenous free
Ca2+ levels measured during certain
electrophysiological responses and buffered levels of exogenous
Ca2+ that can elicit those events (e.g., Johnson and
Byerly, 1993
; Roberts, 1993
; Burgoyne and Morgan, 1995
; Etter et al.,
1996
). Recent measurements suggest a similar correlation for
Mg2+, in that free intracellular
Mg2+ concentrations range from 0.6 to 5 mM (Brocard et al., 1993
) and thus span the range of
Mg2+ levels that gate or regulate ion channels
(e.g., Matsuda et al., 1987
; Stelzer et al., 1988
; Johnson and Ascher,
1990
; O'Rourke et al., 1992
). By comparison, electrophysiological
effects of cytoplasmic Zn2+ have been reported
rarely, and these effects have been obtained with
Zn2+ concentrations that are several orders of
magnitude greater than the picomolar-to-micromolar levels found in
recent histochemical studies (Begenisich and Lynch, 1974
; Woll et al.,
1987
; Frederickson, 1989
; Kokubun et al., 1991
; Groschner and Kukovetz,
1992
; Staley, 1994
; Lascola et al., 1998
; Sensi et al., 1997
).
We therefore tested whether and how neurons are affected
electrophysiologically by lower concentrations of cytoplasmic
Zn2+ and by changes in these levels. For this
purpose, we applied various combinations of Zn2+,
Zn2+-selective chelators, and
Zn2+-preferring ionophores to isolated neuronal
somata during perforated- and ruptured-patch whole-cell patch-clamp
recordings. We specifically tested for these effects in neurons that
contain protein kinase C (PKC) (cf. Cuenca et al., 1990
; Osborne et
al., 1992
), because biochemical studies have shown that
Zn2+ binds PKC and facilitates its activity at
submicromolar concentrations (Murakami et al., 1987
; Csermely et al.,
1988
; Sekiguchi et al., 1988
; Forbes et al., 1991
; Hubbard et al.,
1991
). We present evidence here that intracellular zinc facilitates the
reduction of a "background" Cl
conductance
(Franciolini and Petris, 1990
) by an endogenous PKC in retinal ganglion cells.
The results below are presented in two parts. The first identifies an
outwardly rectifying Cl
current that constitutes a
background Cl
conductance in retinal
ganglion cells. The second part provides evidence that regulation of
this current by endogenous PKC is zinc dependent.
Portions of these data have appeared in a meeting abstract (Tabata and
Ishida, 1997
).
 |
MATERIALS AND METHODS |
Whole-cell recordings. The voltage-clamp currents
described here were measured in single, neurite-free retinal ganglion
cell somata isolated from adult common goldfish (Carassius
auratus). Cells were isolated and identified as described
elsewhere (see Bindokas et al., 1994
; Tabata and Ishida, 1996
; Hidaka
and Ishida, 1998
). Currents were measured in tight-seal whole-cell
configurations, in either ruptured- or perforated-patch mode (Hamill et
al., 1981
; Horn and Marty, 1988
). Experiments were performed at
~23°C within 20 hr of cell isolation, using borosilicate glass
pipettes with tip resistances of 2-3 M
and an Axopatch-1D amplifier
(Axon Instruments, Foster City, CA).
During recording, cells were continuously superfused with a control
bath solution (see below) at a rate of 1.2 ml/min. To reduce the time
required to change extracellular solution composition and to ensure
that current changes were not attributable to mechanical artifacts, we
applied control and test solutions sequentially to cells, either by
switching between fluid reservoirs fed into a microperfusion U-tube or
by shifting the position of a parallel array of glass tubes that each
superfused a different solution over the cells being recorded. As
described elsewhere (Tabata and Ishida, 1996
), command potential
generation, data storage, and off-line analysis were performed with
pCLAMP software (version 6.0.3; Axon Instruments); capacitive currents
were reduced as much as possible by use of the cancellation circuitry
of the amplifier; current signals were analog-filtered at 1 kHz and
digitally sampled at 2 kHz; and liquid junction potentials between
pipette and bath solutions were measured and corrected for before data
collection. Membrane potentials are reported without compensation for
series resistance (mean ± SEM; 18 ± 1 M
in
ruptured-patch mode; n = 65; 32 ± 4 M
in
perforated-patch mode; n = 46) because the total membrane current rarely exceeded 200 pA. Unless otherwise indicated, data are reported here as mean values ± 1 SEM from the indicated number (n) of cells. The current amplitudes reported are the
mean values recorded during the final 20 msec of 100 msec steps to each
test potential. Changes in current amplitudes measured under various
conditions were compared by Wilcoxon rank-sum tests because these
values did not distribute normally. Variances of data measured with
different pipette solutions (e.g., see Fig. 3C) were
compared by F tests (by comparing the ratio of the variances).
Solutions. The compositions of the routinely used pipette
and bath solutions are as follows (exceptions are noted in the figure legends). In ruptured-patch mode, the 30 nM
Zn2+-containing pipette solution consisted of (in
mM): 150 N-methyl-D-glucamine (NMDG), 0.226 CaCl2, 1.7 MgCl2,
3.6 ZnCl2, 2 ATP-Mg, 4 EGTA, and 5 HEPES. The
Cl
concentration in this solution (11 mM) was used for the comparison of equilibrium and reversal
potentials (see Fig. 2). The Zn2+-free pipette
solution contained (in mM): 150 NMDG, 2.48 CaCl2, 1.73 MgCl2, 2 ATP-Mg, 4 EGTA, and 5 HEPES. The Zn2+-free and
Zn2+-containing pipette solutions contained
different amounts of total Ca2+ but identical
amounts of calculated free Ca2+ (see below). The pH
of both of these solutions was adjusted to 7.5 with
D-gluconic acid (DGA). In some experiments, the PKC
catalytic subunit (#539513; Calbiochem, La Jolla, CA), and
PKC[19-31] (#1443 976; Boehringer Mannheim, Indianapolis, IN) were
first dissolved into water to a concentration 1000 times higher than
the final one and then diluted into the Zn2+-free
pipette solution to the final concentration immediately before
experiments. In perforated-patch mode, the pipette tip was filled with
a solution containing (in mM): 150 CsOH, 3.5 CaCl2, 4 MgCl2, 10 BAPTA, and 5 HEPES; pH was adjusted to 7.5 with DGA. The pipette shank was filled
with the above solution mixed at 500:1 with a solution of 3.3% (w/v)
amphotericine B (Sigma, St. Louis, MO) and 10% (w/v) pluronic (P-1572;
Molecular Probes, Eugene, OR) in DMSO.
The concentrations of free divalent cations in each pipette solution
(reported in the text and each figure legend) were calculated using the
equations in Chang et al. (1988)
and the stability constants in Smith
and Martell (1975)
corrected for ionic equivalent, pH, and temperature
according to the method of Marks and Maxfield (1991)
. EGTA was used
instead of BAPTA in these experiments, because dissociation constants
for the binding of Zn2+ by BAPTA are not available.
In the cases of Zn2+-free solutions, the free
Ca2+ and Mg2+ values calculated
as described above did not differ by >20% from those calculated using
the Bound and Determined software (Brooks and Storey, 1992
)
implementing the method of Marks and Maxfield (1991)
. Unless stated
otherwise, the free Ca2+ concentration in all
pipette solutions was set to levels detected in resting retinal
ganglion cells by fura-2 fluorescence intensity [100 nM
(Bindokas et al., 1994
)]. The free Zn2+
concentration in the pipette solution routinely used for ruptured-patch recordings (30 nM) was selected because it falls within the
range of concentrations measured in a variety of intact cells (cf.
Sensi et al., 1997
) and because micromolar Zn2+ has
consistently been found to inhibit PKC activity in biochemical studies
(Murakami et al., 1987
; Csermely et al., 1988
; Sekiguchi et al., 1988
).
We know of no method that could have been used during the
ruptured-patch recordings reported here to demonstrate the precise
distribution and concentration of Zn2+ established
in the cell cytoplasm by exchange with the pipette solution.
The standard bath solution contained (in mM): 105 Na-DGA,
18 NaCl, 0.001 tetrodotoxin (TTX), 0.1 CaCl2, 2.4 CoCl2, 30 tetraethylammonium (TEA)-Cl, 3 4-aminopyridine (4-AP), 10 D-glucose, and 5 HEPES; pH was
adjusted to 7.5 with NaOH and/or HCl. To prepare a test bath solution,
we first dissolved a test agent into an appropriate vehicle solvent to
a concentration 1000 times higher than the concentration to be applied.
This stock solution was kept at
30°C for up to 1 week and diluted
into the bath solution to the final concentration immediately before
experiments. The following solvents were used: water for Rp-cAMP
(Calbiochem) and pyrithione-Na (Aldrich, Milwaukee, WI); ethanol for
N,N,N',N'-tetrakis-(2-pyridylmethyl)-ethylenediamine (TPEN;
Calbiochem); methanol for 4,4'-di-isothiocyanostilbene-2,2'-disulfonic acid (DIDS; Aldrich) and
4-acetamido-4'-isothiocyanostilbene-2-2'-disulfonic acid (SITS;
Aldrich); and DMSO for bisindolylmaleimide I (Calbiochem), calphostin C
(Calbiochem), and 4-bromo-A23187 (4-BrA23187; Calbiochem). The
control bath solution contained the same vehicle solvent as the
corresponding test bath solution.
Three precautions were exercised routinely during this study. First,
the ruptured-patch pipette solution, the perforated-patch pipette
solution, and bath solutions were adjusted with sucrose to 320 ± 5, 330 ± 5, and 330 ± 5 mOsm/kg, respectively. With these osmolalities, neither swelling nor shrinkage of cells occurred after
giga-seal formation. Second, DIDS-sensitive current was measured in
individual cells by digital subtraction of currents recorded before and
during a single application of DIDS, because multiple applications
irreversibly altered the kinetics and degree of
ICl deactivation in many cells and because
retinal ganglion cells possess a K+ current
(IB) that resists block by TEA, 4-AP, and
Cs+ (Lukasiewicz and Werblin, 1988
; Sucher and
Lipton, 1992
). Changes of ICl amplitude produced
by pharmacological treatments that augment or block PKC activity were
gauged either with a single DIDS application at the end of an
experiment or by comparison of the reversal potential and kinetics of
the difference between currents recorded before and during the
pharmacological treatments. Third, voltage-gated cation currents were
suppressed as follows: Na+ current was blocked by
inclusion of 1 µM TTX, Ca2+ currents
were blocked by 2.4 mM Co2+ and reduced
Ca2+ (0.1 mM), K+
currents (except IB) were blocked by 30 mM TEA and 3 mM 4-AP, and
hyperpolarization-activated cation current
(Ih) was suppressed by excluding
K+ from the bath solution (see Bindokas et al.,
1994
; Tabata and Ishida, 1996
; Hidaka and Ishida, 1998
).
 |
RESULTS |
In the presence of pharmacological blockers of voltage-gated
Na+, K+, and
Ca2+ currents (TTX, TEA+, 4-AP,
and Co2+), depolarization of retinal ganglion cell
somata activated an outwardly rectifying current whose amplitude was
reduced by agents that block voltage-gated Cl
current in other tissues. This current appeared to be carried by
Cl
ions
and will be referred to hereafter as
ICl
because its reversal potential shifted with
the chloride equilibrium potential (ECl) calculated from the Cl
ion concentrations in the
bath and pipette solutions used. A current with similar voltage
sensitivity and pharmacological properties was also recorded when
Na+ and K+ in the bath and
recording pipette solutions were replaced by NMDG and
TEA+. ICl activated in every
cell from which we recorded, in ruptured- as well as perforated-patch
recording modes (n = 65 and 51, respectively). When
activated by 100 msec depolarizations from holding potentials between
90 and
70 mV, to test potentials between
80 and +40 mV,
ICl displayed the following pharmacological
properties and voltage sensitivity.
Pharmacology
Several Cl
channel blockers were tested, and
total whole-cell current (between
80 and +40 mV) was reduced in
amplitude by extracellular application of DIDS (n = 61;
e.g., Fig. 1A) and furosemide (data not shown). This reduction by DIDS and the outward rectification recorded under control conditions (Fig.
1B) were not observed if SITS was included in the
pipette solution in ruptured-patch mode (consistent with block of the
DIDS-sensitive current by intracellular SITS; n = 6;
Fig. 1C,D). By contrast, whole-cell current was
unaffected by extracellular applications of 100 µM
picrotoxinin or 500 nM chlorotoxin (n = 3 and 6, respectively; data not shown).

View larger version (17K):
[in this window]
[in a new window]
|
Figure 1.
DIDS and SITS reduce an outwardly rectifying
current in the presence of Na+, Ca2+, and
K+ current blockers. A, Whole-cell current
activated in ruptured-patch mode by the voltage protocol schematically
shown above current traces at
left. The holding potential
(Ehold) was 70 mV; test potentials
(Etest) were from 80 to +40 mV, in
20 mV increments. Currents were recorded before (left)
and during (middle) application of 1 mM
DIDS. Subtraction of these currents yields DIDS-sensitive current
(right). The difference current appears to activate
rapidly, not inactivate, and then deactivate rapidly (at onset,
plateau, and offset, respectively, of each test depolarization). In
this and all other current traces, the zero current
level is shown by a dotted line. B,
Current-voltage (I-V) curve of the
DIDS-sensitive current in A. In this and all other
I-V curves, current amplitude is averaged over the
final 20 msec of 100 msec steps to each test potential and then plotted
against test potential. Current reverses direction near
ECl ( 40 mV). C, Whole-cell
current recorded from a cell different from that in A
before (left) and during (middle)
application of 1 mM DIDS. Current was activated and
recorded as described in A, except that 100 µM SITS was included in the recording pipette solution.
Ionic current recorded under this condition is unaffected by 1 mM DIDS; the difference between currents before and during
DIDS (right) is due to slight capacitive current changes
only. D, I-V curve measured from the
difference of currents in C. The calculated free
concentration of Zn2+ in the pipette solution
([Zn2+]pip) was 30 nM.
|
|
Nearly maximal reduction of the control current amplitude was produced
by 1 mM DIDS. The current that resisted block by 1 mM DIDS constituted approximately one-third of the total
outward current recorded at a test potential of +40 mV. When normalized to cell capacitance (Cm), the amounts of current that
resisted block by DIDS resembled the total whole-cell current recorded (at +40 mV) with pipette solutions that contained 300 µM
SITS (0.4 ± 0.4 pA/pF; n = 6; see Fig.
1C). These DIDS- and SITS-resistant currents were not
examined in detail. However, after repolarization to the holding
potential, the amplitude of the "tail" of these currents was
K+-sensitive (n = 31; data not
shown). We presume that this current is analogous to the TEA- and
4-AP-resistant cation current termed IB
in retinal ganglion cells of other species (Lukasiewicz and Werblin,
1988
; Sucher and Lipton, 1992
) and that it is carried by other cations
(primarily Na+ in ruptured-patch mode and
Cs+ in perforated-patch mode) under our recording
conditions, as in other neurons (Zhu and Ikeda, 1993
; Callahan and
Korn, 1994
). This observation indicates that, at the concentrations
used, DIDS did not abolish voltage-sensitive currents nonselectively in
the cells from which we recorded.
Charge carrier and Ca2+ insensitivity
Two results indicated that 1 mM DIDS reduced the
amplitude of a Cl
current in retinal ganglion
cells under the recording conditions used here. First, as mentioned
above, this current reversed in direction at a membrane potential that
shifted with extracellular Cl
concentration (Fig.
2). When the external
Cl
concentration was changed from 53 to 11 mM (by isosmotic replacement with D-gluconic
acid, with the internal Cl
concentration fixed at
11 mM), the reversal potential of the DIDS-sensitive
current shifted from
36 ± 2 mV (n = 9) to
3 ± 3 mV (n = 4). These results suggest that
this current is carried at least primarily by Cl
ions, as characteristically found in background Cl
currents of various cells (Franciolini and Petris, 1990
). (From the
bath and pipette solution compositions, the equilibrium potentials for
Na+ and Ca2+ ions are estimated
to have been extremely positive values and to have remained constant
while the Cl
reversal potential changed during
these measurements.) Second, the reversal potential of the
DIDS-sensitive current was unaffected by a 59 mV shift in the
H+ equilibrium potential (produced by 0.5 pH unit
increases and decreases in extracellular pH; n = 6;
Fig. 2). Our records thus showed no detectable amounts of the
DIDS-sensitive proton current described in human macrophages
(Holevinsky et al., 1994
).

View larger version (12K):
[in this window]
[in a new window]
|
Figure 2.
Cl , not
H+, carries DIDS-sensitive current. Interpolated
values of reversal potential (Erev)
of DIDS-sensitive current (measured as described in Fig.
1B) listed next to Cl and
H+ equilibrium potential values
(ECl and
EH, respectively) set by bath and
pipette solution compositions. Ruptured-patch recording mode was used.
The control bath solution contained 53 mM
Cl , the bath Cl was reduced
to 11 mM by isosmotic replacement with DGA. The pipette
solution contained 11 mM Cl and 30 nM free Zn2+ (see Materials and Methods
for other constituents). Filled circles and error bars
plot the mean ± 1 SEM of Erev measured
from the indicated number of cells. Erev of
DIDS-sensitive current shifts with ECl but
not with EH.
|
|
Two results indicated that the DIDS-sensitive current was not gated by
intracellular Ca2+. First, no increases in current
amplitude were detected when cells were exposed to a divalent cation
ionophore (4-BrA23187) in the presence of 0.1 mM
Ca2+ (n = 5; see Fig. 5 and its
description below). Second, the DIDS-sensitive current density (current
amplitude normalized to cell membrane capacitance) did not
significantly differ when measured in ruptured-patch mode with pipette
solutions containing calculated free Ca2+ levels of
10, 30, and 300 nM (n = 4, 5, and 3, respectively; data not shown). Although the density of
ICl was indistinguishable when these different
pipette solutions were used, the total depolarization-activated outward
current density more than doubled at +40 mV (the test potential used
routinely to characterize ICl) when these
solutions contained K+ rather than NMDG as the major
monovalent cation and when the calculated free Ca2+
level was increased from 10 to 300 nM. These results are
consistent with the presence of a Ca2+-activated
K+ conductance in goldfish retinal ganglion cells,
not unlike that suggested by measurements in salamander, turtle, rat,
and cat retinal ganglion cells (see Ishida, 1995
). By contrast, the
activation of the ICl we report here apparently
does not require increases in cytoplasmic Ca2+ and
thus differs from the Ca2+-activated
Cl
current of rod and cone photoreceptors, retinal
bipolar cells, and other central neurons (Bader et al., 1982
; Maricq
and Korenbrot, 1988
; Okada et al., 1995
).
On the basis of the above results and to obviate the need for
leak-current subtraction, we measured ICl in the
remainder of this study by the difference between whole-cell current
recorded before and during application of 1 mM DIDS. The
amplitude, reversal potential, and kinetics of
ICl were measured from these "difference currents." In some cases, we also inferred that
ICl was susceptible to regulation by
pharmacological agents that affect protein kinase activities, if the
difference currents recorded before and during application of these
agents resembled the DIDS difference currents.
Gating in ruptured- and perforated-patch modes
The activation range of ICl included
membrane potentials that were more negative and more positive than the
ECl routinely used in our experiments (
40 or
32 mV); ICl was inward at test potentials more
negative than ECl, and it was outward at
more positive test potentials (see Figs. 1B,
7H). The chord conductance measured from outward
currents exceeded that measured from inward currents when the bath and
pipette solutions contained equal Cl
concentrations and when the standard bath and pipette solutions were
used (bath, 53 mM Cl
; pipette, 11 mM Cl
). When the bath and pipette
solutions both contained 11 mM Cl
, for
example, the outward ICl at +40 mV was 2.9 ± 0.3 (n = 4) times larger in amplitude than the
inward ICl measured at
40 mV.
Over the range of test potentials we routinely used (i.e., between
80
and +40 mV), ICl did not exhibit markedly
time-dependent gating kinetics. First, its rise time was both rapid and
not obviously voltage dependent; the rising edge of currents measured
after depolarizations to test potentials between
40 and +40 mV could all be fitted by single-exponential time constants of 3-5 msec. Second, ICl was not detectably inactivated by
depolarization because it did not decline in amplitude during sustained
depolarizations (Fig. 1) and because the currents activated by
depolarizations from
90 to +20 mV were identical in amplitude to
those activated by depolarizations from
30 to +20 mV
(n = 5; data not shown). Third, tail currents were
immeasurably small, and thus ICl displayed no
time-dependent deactivation (Fig. 1).
It was possible to activate ICl of stable
amplitude repeatedly in perforated-patch mode but not in ruptured-patch
mode with the standard pipette solution. This was gauged, as explained
above, in two steps. The total whole-cell current was measured during the last 20 msec of 100 msec depolarizations, repeated once per 60 sec,
from a holding potential of
70 mV to a test potential of +40 mV; 1 mM DIDS was then applied to determine the fraction of the
total current that was comprised by ICl. During
ruptured-patch recordings, the amplitude of the total test current
increased continuously and by as much as 10-fold or more during the
course of 30 min (Fig. 3A). We
infer that this increase in total whole-cell current is attributable
primarily, if not entirely, to increases in ICl
because 1 mM DIDS blocked approximately all of the total current that (by the end of each recording) exceeded the levels recorded at the beginning of each recording (Fig. 3A; the
possibility that higher concentrations of DIDS might produce larger
reductions in the whole-cell current was not tested). During these
long-term recordings, the slowly rising current recorded during the
first few milliseconds of each test depolarization and the total
whole-cell current tail recorded after repolarization to the holding
potential did not markedly change in amplitude. These current
components therefore vanished upon subtraction of the current traces
recorded in the presence and absence of DIDS (Fig. 1), leaving traces
that show no time-dependent activation or deactivation (of
ICl). The steady growth of
ICl illustrated by Figure 3A was
never seen in perforated-patch mode. Instead, the amplitude of the
total current decreased within the first 5-10 min of giga-seal
formation and was stable thereafter for at least 30 min (Fig.
3B). The initial decline in current amplitude presumably
reflects the slow replacement of intracellular K+ by
Cs+ in the pipette solution.

View larger version (18K):
[in this window]
[in a new window]
|
Figure 3.
Exogenously supplemented intracellular
Zn2+ impedes augmentation of
ICl by intracellular perfusion.
A, B, Amplitude of total current at
Etest of +40 mV plotted against recording
time. Recordings in A and B were in
ruptured- and perforated-patch mode, respectively. Pipette solutions in
both recordings contained no added zinc
([Zn2+]pip = 0); 1 mM
DIDS was microperfused onto the cell during the time indicated by the
horizontal bar in A.
Cm, 10 pF in A and 28 pF in B. C,
ICl activated by depolarization to +40 mV
after 12-15 min of intracellular perfusion with
Zn2+-free versus Zn2+-containing
pipette solutions. Each circle plots the increase in
amplitude of ICl over this time for a
different cell, normalized by the Cm of that
cell. Horizontal bars plot the mean of values for each
pipette solution [mean ± SD; 2.6 ± 2.3;
n = 7 cells for
[Zn2+]pip = 0 nM
(open circles); 1.1 ± 0.6; n = 6 for [Zn2+]pip = 30 nM (filled circles)].
|
|
It was technically infeasible to quantify the rate at which
ICl increased over time in ruptured-patch mode
by alternating applications of control and DIDS-containing bath
solution, because applications of DIDS produced changes in the
deactivation kinetics of the total current. Nevertheless, the above
results imply that at least some of the current measured during 100 msec test depolarizations may be regulated via an intracellular
molecule or mechanism that was lost or compromised by exposure to the
ruptured-patch pipette solution. These results also indicate that the
slowly rising and tail current components can both be activated
repeatedly, without substantial change, in ruptured- as well as
perforated-patch recordings.
Regulation of ICl by a
zinc-dependent mechanism
We tested the possibility that the increase in amplitude of
ICl during recordings in ruptured-patch mode
resulted from chelation of cytoplasmic Zn2+ by EGTA
in the pipette solution rather than from chelation of Ca2+. We tested this possibility because
Zn2+ has been detected in the cytoplasm of various
central neurons (Frederickson, 1989
) and because EGTA binds
Zn2+ with a greater affinity than it does other
divalent cations (e.g., Ca2+ and
Mg2+; see Materials and Methods). A first test of
this possibility was made by including Zn2+ in the
pipette solution used in ruptured-patch mode. When
Zn2+ was included in the pipette solution at a free
concentration calculated to be 30 nM, the density of
ICl (measured at 12-15 min after membrane
rupture) ranged from 0.3 to 1.8 pA/pF (mean ± SD; 1.1 ± 0.6; n = 6). Without an exogenous supplement of
Zn2+, ICl density ranged from
0.5 to 7.2 pA/pF (mean ± SD; 2.6 ± 2.3; n = 7; Fig. 3C). The variance of the current densities measured with the Zn2+-free pipette solution was
significantly larger than that measured with the
Zn2+-containing pipette solution
(p < 0.01, F test), suggesting that the growth of ICl was often facilitated by the
replacement of cytoplasmic constituents by a
Zn2+-free solution and that this growth was hindered
by the inclusion of Zn2+ in the pipette solution.
Large increases in ICl were not observed with
pipette solutions containing a calculated free Zn2+
concentration of 3 nM (n = 2). However,
ICl densities were not compared in detail at
different pipette Zn2+ concentrations because we had
no means to ascertain the Zn2+ levels established
within cells during the recordings attempted here. Under both
conditions studied (30 nM vs no free
Zn2+), the difference between currents measured
before and after DIDS application displayed outward rectification,
rapid activation, no inactivation, and no time-dependent deactivation.
A second test of whether the availability of cytoplasmic
Zn2+ abated the growth of ICl
was made by superfusing cells with the membrane-permeable
Zn2+-selective chelator TPEN (Arslan et al., 1985
)
in perforated-patch mode. At 10 µM, TPEN increased the
amplitude of the total whole-cell current at a test potential of +40 mV
(Fig.
4A,E).
The TPEN-augmented difference current (obtained by subtraction of
currents recorded before and after application of TPEN) was
indistinguishable from ICl in that it rectified
outwardly, reversed direction at
27 ± 3 mV (when
ECl was
32 mV; n = 5; see Fig.
4 for details), and lacked the inward tail component recorded both in
the presence and absence of DIDS (Fig. 1A). This
effect of TPEN was prevented by coapplication (of TPEN) with
Zn2+ (Fig. 4C,D), as expected
because TPEN is membrane impermeant when it has complexed with
Zn2+ (Arslan et al., 1985
).

View larger version (29K):
[in this window]
[in a new window]
|
Figure 4.
The membrane-permeable Zn chelator TPEN augments
total whole-cell current (Itotal).
A, Amplitude of Itotal
activated by depolarization from 70 to +40 mV, in perforated-patch
mode, before and after application of TPEN (10 µM;
indicated by horizontal bar) is shown. Here and in all
subsequent figures, application of the test agent of interest begins at
0 min; current measurements before 0 min (with or without conditioning
agents) are plotted against negative time values. Note that the
increase in current peaks at 6-8 min after TPEN application begins.
B, Difference between currents activated before and
after TPEN at test potentials between 80 and +40 mV is shown.
C, D, TPEN (10 µM) fails to
augment Itotal when coapplied with equimolar
Zn2+. E, The current density change
produced by TPEN and by a mixture of TPEN and Zn2+
at +40 mV is shown. Current density measured 8 min after drug
application began, minus that at 1 min before drug application, is
plotted (filled vertical bars and error bars plot
mean ± 1 SEM, respectively; n = 5 for each
treatment). The mean change with TPEN is significantly larger than that
with TPEN and Zn2+ (*p = 0.0216). F, I-V relation of
TPEN-augmented current is shown (filled circles
and error bars plot mean ± SEM, respectively;
n = 5). Amplitude is normalized to the value at +40
mV and plotted against test potential.
Erev, 27 ± 3 mV;
ECl, 32 mV. In all panels, currents
were recorded in the control bath solution before TPEN application.
TPEN was then superfused for 3-4 min after replacing the bath
Co2+ with Ca2+ (because TPEN
binds Co2+ more than Ca2+ and
only unbound TPEN can pass through cell membranes). Effects of TPEN
were assessed by recording currents after replacing the TPEN- and
Ca2+-containing solution with control
(Co2+-containing) solution to bind residual TPEN (if
any) and to block voltage-gated Ca2+ currents.
|
|
A third test of the effect of cytoplasmic Zn2+ on
ICl was made by microperfusing a mixture of
Zn2+ plus an ionophore that conducts
Zn2+ onto cells during recordings in
perforated-patch mode. As shown in Figure
5A, the amplitude of outward
current activated at a test potential of +40 mV declined in amplitude
(Fig. 5A,B,E) after the
coapplication of 1-100 µM Zn2+ either
with 4-BrA23187 [10 µM (Erdahl et al., 1996
)] or with pyrithione [20-100 µM (Zalewski et al., 1993
)]. When
coapplied with 4-BrA23187, 1 µM Zn2+
(n = 3), 10 µM Zn2+
(n = 5), and 100 µM
Zn2+ (n = 3) produced declines of
similar amplitude. Neither Zn2+ nor 4-BrA23187 alone
reduced Itotal at the concentrations used here,
and moreover, similar declines in Itotal were
produced by the coapplication of Zn2+ and 4-BrA23187
when the coapplication was preceded by an application of
Zn2+ alone (n = 8) or of 4-BrA23187
alone (n = 3). This suggests that the decline in
Itotal resulted from rises in intracellular
Zn2+ concentration and not from a
4-BrA23187-mediated influx of Ca2+ or from an
effect of Zn2+ on the external membrane surface. The
zinc-damped difference current obtained by subtraction of currents
recorded before and after these treatments was indistinguishable from
ICl in that it rectified outwardly, reversed
direction close to ECl (Fig. 5F), and displayed no time-dependent deactivation.
The decline produced by coapplication of Zn2+ and
pyrithione was small (0.5 pA/pF; n = 2) and not
examined in detail.

View larger version (23K):
[in this window]
[in a new window]
|
Figure 5.
Effects of Zn2+ "loading"
and PKC inhibition on total whole-cell current
(Itotal) in perforated-patch mode.
The cytoplasmic Zn2+ level was raised by
extracellular application (indicated by horizontal
bars) of ZnCl2 (Zn) together
with the Zn2+-preferring ionophore 4-BrA23187
(BrA). Endogenous PKC was blocked by preincubation with
calphostin C (CC). A, C,
Amplitude of Itotal at +40 mV plotted
against recording time. Each panel is from a single
cell. The dotted line indicates current level before
coapplication of Zn and BrA.
A, Sequential application of 100 µM
Zn and 10 µM BrA.
Itotal begins to decline after coapplication
commences (at t = 0 min); within the next 8 min, current
reduction is maximal. C, Sequential application of 10 µM Zn and 10 µM
BrA, preceded by a 30 min preincubation in 1 µM CC. Itotal
remains constant during the 10 min coapplication of Zn
and BrA. B, D, Difference
between Itotal recorded 1 min before and 10 min after coapplication of Zn and BrA.
Current traces in B and D
are from cells in A and C, respectively.
The voltage protocol is as described in Figure 1
(Ehold, 70 mV;
Etest, 80 to +40 mV; 20 mV steps).
E, Reduction in Itotal after
10 min coapplication of Zn and BrA, with
and without 30 min preincubation in 1 µM
CC. Filled vertical bars and error bars
plot the mean and SEM, respectively, of the reduction in current
amplitude at +40 mV, divided by Cm to
normalize for cell size. Current reduction by Zn is
significantly greater without CC than with
CC (*p = 0.0058), indicating that
reduction of ICl by Zn can be
blocked by inhibition of endogenous PKC. CC/Zn & BrA,
Coapplication of 10 µM Zn and 10 µM BrA after preincubation
(n = 5); Zn & BrA, coapplication of
1-10 µM Zn and 10 µM
BrA without preincubation (n = 7).
F, I-V curve of current reduced by
coapplication of Zn (1-10 µM) and
BrA (10 µM). Filled circles
plot the mean of difference current amplitudes measured as described in
B (n = 6). Means are normalized to
the value at +40 mV. Error bars indicate 1 SEM.
Erev, 34.5 ± 5 mV.
|
|
Downward regulation of ICl by an
endogenous, zinc-dependent PKC
The results described in the preceding section suggest that the
amplitude of whole-cell ICl is downwardly
regulated, either directly or indirectly, by cytoplasmic
Zn2+. We tested the possibility that this effect is
exerted indirectly for four reasons: (1) because studies of direct
Zn2+ effects on Cl
channels in
other cell types used substantially higher Zn2+
concentrations than those used here (see introductory remarks), (2)
because biochemical assays have shown that (aside from modulating ion
channel activities) Zn2+ facilitates PKC activity
(e.g., Murakami et al., 1987
; Csermely et al., 1988
), (3) because PKC
has been found to modulate Cl
currents in a
variety of cells (e.g., Madison et al., 1986
; Li et al., 1989
; Kokubun
et al., 1991
; Tricarico et al., 1991
; Kawasaki et al., 1994
; Staley,
1994
; Coca-Prados et al., 1995
; Duan et al., 1997
), and (4) because PKC
has been localized by immunocytochemical methods to retinal ganglion
cells of the species used here (Osborne et al., 1992
). We therefore
tested whether ICl is regulated by endogenous
PKC activity and whether this control was zinc dependent.
We first tested the effect of extracellularly applied PKC inhibitors on
ICl in perforated-patch mode. Both agents tested
(0.1-1 µM calphostin C and 1 µM
bisindolylmaleimide I) (cf. Shapiro et al., 1996
) produced an increase
in the amplitude of the total outward current (n = 4 for each agent; Fig. 6G). At a
test potential of +40 mV, current amplitude increased noticeably (e.g.,
by 10-20%) over the control value within 4-8 min after
application of either agent (Fig.
6A,C). Current amplitude continued
to increase thereafter during applications of either agent for as long
as 10-15 min. We infer that increases in the amplitude of
ICl account for most (if not all) of the
increases in outward current observed, because the latter were reduced
by DIDS (1 mM) and because the kinetics and voltage
sensitivity of the difference current traces obtained by subtraction of
currents recorded before and after exposure to PKC inhibitors (Fig.
6B,D,H) resemble
those of the Cl
current described above (Fig. 1).
These results suggest that ICl is reduced in
resting retinal ganglion cells by an endogenous PKC activity.

View larger version (30K):
[in this window]
[in a new window]
|
Figure 6.
Effect of membrane-permeable PK inhibitors on
ICl in perforated-patch mode.
A, C, E, Amplitude of
total current (Itotal) at +40 mV
before and after application (indicated by horizontal
bars) of inhibitors of PKC and PKA. Each recording is
from a different cell. Concentrations used were 0.1 µM
calphostin C (CC), 1 mM DIDS, 1 µM bisindolylmaleimide I (Bis I),
and 0.1 mM Rp-cAMP. Amplitudes of
Itotal start to increase 4-8 min after
CC (A) and Bis I
(C) applications begin, and grow continuously and
gradually thereafter. DIDS (applied at times indicated by short
horizontal bars) reduces current toward the levels before
CC and Bis I. B,
D, F, Difference between currents
recorded before and after 13-21 min application of various test
agents. Data in B, D, and
F were obtained from the same cells shown in
A, C, and E, respectively.
Calibration (in B) is the same in all
panels. The kinetics of difference currents in
B and D (i.e., of currents augmented by
CC and by Bis I) resembles those
of ICl in Figure 1. G, Mean
change in density of Itotal at +40 mV after
15-20 min application of various test agents. Bis I, 1 µM Bis I; CC, 0.1-1
µM CC; cntrl, control bath
solutions supplemented with vehicle (DMSO) only; Rp,
0.1-1 mM Rp-cAMP (n = 4 for each
treatment). The mean change with CC and Bis
I is significantly larger than the control level
(*p > 0.0209 for both). H,
I-V relation of current augmented by CC
(filled circles) and Bis I
(open circles). Amplitude was normalized to the maximum
value recorded from each cell at +40 mV and plotted against test
potential. Symbols and error bars plot the mean ± SEM, respectively (n = 4 for each treatment).
Voltage sensitivity of these currents resembles those of
ICl in Figure 1.
Erev of CC- and
Bis I-augmented currents, 27 ± 8 and
28 ± 3 mV, respectively; ECl,
32 mV.
|
|
As might therefore be expected, DIDS-sensitive current was undetectably
small when PKC catalytic subunit (~4 pM) was included in
pipette solutions during ruptured-patch recordings (n = 5; Fig. 7A). Moreover,
DIDS-sensitive current (ICl) could be
activated when a PKC inhibitor (PKC[19-31]) (cf. Lin et al., 1994
)
and PKC catalytic subunit were included together in the pipette
solution during ruptured-patch recordings (n = 5 for
each treatment; Fig. 7). Therefore, the observed reduction of
ICl amplitude cannot be ascribed to nonspecific
effects of the PKC catalytic subunit (i.e., effects beside
phosphorylation).

View larger version (14K):
[in this window]
[in a new window]
|
Figure 7.
Downregulation of
ICl by PKC-mediated phosphorylation.
A, Currents activated by depolarization from 70 to +40
mV before (left column) and during (middle
column) application of 1 mM DIDS and with digital
subtractions thereof (right column). Each
row of currents is from a separate cell, with the
ruptured-patch pipette solution containing no peptide (top
row), 4 pM PKC catalytic subunit (middle
row), or a mixture of 4 pM PKC catalytic subunit
and PKC inhibitor [1 µM PKC(19-31)] (bottom
row). DIDS was applied to each cell 9-15 min after formation
of ruptured-patch-recording mode. The flat difference
current in the middle row shows that there is no
current blocked by DIDS in the presence of PKC. The DIDS-sensitive
difference current in the bottom row shows
ICl spared by PKC inhibition.
B, Density of DIDS-sensitive currents measured as
described in A. Filled vertical bars and
error bars plot the mean ± SEM; n = 5 for
each treatment. In each recording, the pipette solution contained 2 mM ATP and no added Zn2+. Mean density
is significantly reduced by PKC from the control (no peptide) level
(*p = 0.0122). Mean density with PKC(19-31) is
significantly larger than those with PKC only (#p = 0.0122).
|
|
Lastly, we tested whether the downward regulation of
ICl by endogenous PKC and that by cytoplasmic
Zn2+ were linked. This was done by measuring
Itotal in the presence of calphostin C,
Zn2+, and 4-BrA23187. Figure 5, C and
E, shows that 10 µM Zn2+
and 10 µM 4-BrA23187 did not reduce the amplitude of
Itotal in cells incubated for 30 min in 1 µM calphostin C. The subtraction of currents recorded in
the presence of all three agents from those recorded in the presence of
Zn2+ and calphostin C alone showed no measurable
difference current at any of the test potentials used
(n = 5; Fig. 5D; only slight changes in
capacitive current artifacts are seen at the onset and offset of the
test potentials). The current reduction by Zn2+ was
significantly less after
30 min preincubations with calphostin C than without it (Fig. 5E; p = 0.0058),
indicating that inhibition of endogenous PKC impeded the reduction of
ICl by Zn2+. Consistent with
this and with the lag observed between calphostin C application and
ICl augmentation (e.g., Fig. 6),
ICl amplitude grew monotonically if 10 µM Zn2+ and 10 µM
4-BrA23187 were coapplied after a 10 min (rather than 30 min) exposure
to 1 µM calphostin C (n = 5; data not
shown). All of these results would be expected if the reduction of
ICl by cytoplasmic Zn2+ (like
that shown in Fig. 5A) was mediated by PKC.
Under the same recording conditions in which PKC inhibitors increased
ICl, the Rp-isomer of cAMP (0.1-1
mM) produced no detectable change in
ICl when applied onto cells by microperfusion
for as long as 25 min (Fig. 6G,H).
Because Rp-cAMP is a membrane-permeable inhibitor of protein kinase A
(PKA) and because the concentrations used are 10-100 times greater
than its Ki, we did not further test
whether endogenous PKA activity regulates
ICl.
 |
DISCUSSION |
We have described here an outwardly rectifying
Cl
current (ICl)
whose amplitude appears to be downwardly regulated in a zinc-dependent manner by an endogenous PKC. Below, we discuss the role of zinc in
suppressing this current, compare this current with anionic conductances in other cells, and delimit speculation about the function
of this current.
Indirect effects of Zn2+
Previous studies showed that the open time of outward
single-channel Cl
currents is reduced by
application of 1-10 mM Zn2+ to the
cytoplasmic side of isolated membrane patches and interpreted these
effects as resulting from a voltage-dependent block (Woll et al., 1987
;
Kokubun et al., 1991
; Groschner and Kukovetz, 1992
). Our results might
seem similar in that exposure of cells to Zn2+ and
either 4-BrA23187 or pyrithione reduced the amplitude of outward
whole-cell Cl
current (Fig. 5). However, our
results differ from these previous reports in at least three respects.
First, both inward and outward Cl
current
amplitudes were augmented by pharmacological treatments that chelate
cytoplasmic Zn2+ (exposure to TPEN; buffering
divalent cation levels in nominally Zn2+-free
ruptured-patch pipette solutions with EGTA); conversely, both currents
were reduced by treatments designed to augment intracellular Zn2+ levels (Figs. 3A,
4B, 5B). These results are not readily
explained by assuming a voltage-dependent block by
Zn2+ like that considered in the outward
Cl
current measurements cited above. Second,
inclusion of 30 nM free Zn2+ in our
pipette solutions was effective in minimizing Cl
current increases in the ruptured-patch recording mode. This implies
that ICl may be controlled by
Zn2+ concentrations several orders of magnitude
lower than those applied in the studies cited above (without excluding
the possibility that higher Zn2+ concentrations
might hinder Cl
channel gating in retinal ganglion
cells) (cf. Staley, 1994
). Third, we found that the effect of
exogenously supplied cytoplasmic Zn2+ was blocked by
the PKC inhibitor calphostin C. This suggests that
ICl was not inhibited by Zn2+
alone. If increased cytoplasmic Zn2+ levels reduced
ICl independently of PKC in our recordings, then these decreases were so small that they were outweighed by the increases in ICl produced by PKC inhibition
(Fig. 5E).
The similarly slow and marked growth in Cl
current
amplitude we observed after exposure to calphostin C and
bisindolylmaleimide I, superfusion with TPEN, and internal perfusion
with EGTA (without added Zn2+) would all be expected
if ICl was downregulated by a PKC whose activity
depends on Zn2+. Alone, any one of these results
would have corroborated the results of previous studies, as
Cl
current blockade by Zn2+ at
the cytoplasmic side of membranes and the downward regulation of
Cl
current by PKC have been described separately
in other preparations (cited both above and below). Furthermore, PKC
has been localized immunocytochemically to retinal ganglion cells in
all species examined to date (e.g., Cuenca et al., 1990
; Usuda et al.,
1991
; Osborne et al., 1992
; Kolb et al., 1993
; Fukuda et al., 1994
). To
our knowledge, however, the zinc dependence of the downward regulation
of a Cl
current by PKC that we report here is
novel. For that matter, our study provides the first
electrophysiological evidence consistent with biochemical measurements
of zinc-dependent PKC activity in other systems (Murakami et al., 1987
;
Csermely et al., 1988
; Hubbard et al., 1991
). This possibility was not
predictable from immunocytochemical studies, as several PKC isozymes
have been localized to retinal ganglion cells (e.g., Usuda et al.,
1991
; Osborne et al., 1992
; Kolb et al., 1993
), Zn2+
has not been detected anatomically in retinal ganglion cells (Ugarte
and Osborne, 1998
), and Zn2+ that is bound to PKC
would not be detectable by any anatomical methods that we are aware of
(Frederickson, 1989
; Sensi et al., 1997
). However, one of the
PKC isozymes (PKC-
) localized to retinal ganglion cells of the
species used in this study (Osborne et al., 1992
) is a type whose
activity has been shown by biochemical methods to be zinc dependent
(Murakami et al., 1987
; Csermely et al., 1988
; Hubbard et al., 1991
).
Our results provide independent evidence of such activity, and in the
absence of other candidates, we provisionally attribute the PKC- and
zinc-dependent regulation of Cl
current to this
isozyme. This possibility could be of general interest because PKC-
has also been localized in frog, turtle, rabbit, monkey, and human
retinal ganglion cells (Cuenca et al., 1990
; Usuda et al., 1991
;
Osborne et al., 1992
; Kolb et al., 1993
; Fukuda et al., 1994
).
Cl
current identification
Four types of Cl
current have been found
previously to be reduced in amplitude by PKC activity. However, none of
these currents are known to have all of the properties we report here.
The Cl
current blocked by PKC activation in
hippocampal pyramidal cells is activated by hyperpolarization and
rectifies inwardly (Madison et al., 1986
; Staley, 1994
); large
single-channel anion currents recorded after PKC inhibition or membrane
patch excision (Kokubun et al., 1991
; Groschner and Kukovetz, 1992
)
display bell-shaped activation curves; Cl
channels
are inactivated by PKC in normal and cystic fibrosis airway epithelia,
but only at cytoplasmic Ca2+ concentrations >150
nM (Li et al., 1989
); and background
Cl
currents that are reduced by PKC in other
preparations [skeletal muscle (Tricarico et al., 1991
); renal and
cardiac ClC-3 channels (Kawasaki et al., 1994
; Duan et al.,
1997
); and ciliary epithelium (Coca-Prados et al., 1995
)] have yet to
be examined for cytoplasmic Zn2+ sensitivity.
Cytoplasmic Ca2+ inhibits ClC-3 channel currents
(Kawasaki et al., 1995
) at levels that did not noticeably alter the
ICl reported here. However, the significance of
this difference remains to be investigated, because the inhibition by
Ca2+ was observed under conditions unlike ours (in
the presence of a protein kinase inhibitor and alkaline phosphatase,
and in the absence of ATP and Zn2+) and because we
have been unable to make stable whole-cell recordings from retinal
ganglion cells in hypotonic or isotonic bath solutions (see Materials
and Methods).
The background ICl we have found in retinal
ganglion cells also appears to be distinct from all five types of
Cl
current described in other retinal cells.
ICl was not detectably affected by cytoplasmic
Ca2+ levels buffered (nominally) to between 3 and
300 nM and thus differs from the
Ca2+-activated Cl
current of
photoreceptor and bipolar cells (see Results). In addition,
ICl was not blocked by picrotoxinin and thus
differs from Cl
channels complexed with
GABAA, GABAC, and glycine
receptors (see Wang et al., 1995
). Lastly, ICl
was not affected by Rp-cAMP and thus differs from the
Cl
conductance in pigmented epithelial cells
(Peterson et al., 1997
). Coincidentally, protein kinase activities have
been found to reduce the amplitude of sustained Cl
currents found so far in all retinal cells, regardless of the conditions under which they activate [resting voltage (Fig. 1) or
exposure to GABA (Feigenspan and Bormann, 1994
), glycine (Han and
Slaughter, 1998
), and cytoplasmic Ca2+ (Peterson et
al., 1997
)].
Cl
current function
Our results indicate that retinal ganglion cells possess at least
two resting ion conductances. One is permeable to K+
ions (Bindokas et al., 1994
), whereas the other is the
Cl
conductance reported here. Like the ohmic
conductance recorded between
105 and
55 mV in the absence of
extracellular K+ ions (Tabata and Ishida, 1996
),
ICl showed no time-dependent activation,
inactivation, or deactivation. On the other hand, the relatively small
density of ICl near resting potential and its
nonlinear dependence on voltage are characteristic of background Cl
currents in various tissues (Franciolini and
Petris, 1990
). Regardless of its gating mechanism,
ICl was consistently detected at test potentials
as negative as
80 mV, suggesting that ICl is
tonically activated in situ at membrane voltages at least as
negative as the resting potential.
Because resting potential is relatively close to the
K+ equilibrium potential, even if the
Cl
equilibrium potential is raised to 0 mV
(Ishida, 1995
), K+ conductance evidently contributes
more to resting potential than the Cl
conductance
reported here (see also Ascher et al., 1976
). However, our results
imply that the contribution of ICl to resting
potential and other electrical properties of cells (membrane time
constant, input impedance, and synaptic integration) might not be
fixed. Conceivably, these contributions could be augmented or
diminished, given our observation that the Cl
permeability rises if recording conditions deplete cytoplasmic Zn2+ or inhibit PKC and that its resting level can
be decreased by treatments that augment cytoplasmic
Zn2+. Moreover, these contributions could be altered
slowly and persistently by synaptic modulation of PKC activity, because
ICl showed no susceptibility to inactivation by
membrane potential. Lastly, because we recorded
ICl at membrane potentials that are more
negative and more positive than typical resting potentials, and because retinal ganglion cells are inhibited by GABA- and glycine-gated Cl
conductances in situ, a background
Cl
permeability may provide retinal ganglion cells
with a means of reducing the driving force for Cl
currents (and thus, of reducing membrane potential fluctuations) without obviating shunting types of inhibition. Until more is known
about PKC regulation and the distribution of ICl
within retinal ganglion cells in situ, we refrain from
further speculation about its possible functions.
 |
FOOTNOTES |
Received Feb. 24, 1999; revised April 8, 1999; accepted April 12, 1999.
This work was supported by National Institutes of Health Grant EY 08120 from the National Eye Institute (Bethesda, MD) to A.T.I. We thank
Professor Philippe Ascher for helpful criticism of this manuscript,
Professors Yutaka Fukuda and Masanobu Kano for the opportunity to
pursue this study, and Ms. Gloria Partida for preparing the primary
cell cultures used in these experiments.
Correspondence should be addressed to Dr. Andrew T. Ishida, Section of
Neurobiology, Physiology, and Behavior, University of California, One
Shields Avenue, Davis, CA 95616-8519.
Dr. Tabata's present address: Department of Physiology, Kanazawa
University School of Medicine, Kanazawa, Ishikawa 920-8640, Japan.
 |
REFERENCES |
-
Arslan P,
Di Virgilio F,
Beltrame M,
Tsien RY,
Pozzan T
(1985)
Cytosolic Ca2+ homeostasis in Ehrlich and Yoshida carcinomas.
J Biol Chem
260:2719-2727[Abstract/Free Full Text].
-
Ascher P,
Kunze D,
Neild TO
(1976)
Chloride distribution in Aplysia neurones.
J Physiol (Lond)
256:441-464[Medline].
-
Bader CR,
Bertrand D,
Schwartz EA
(1982)
Voltage-activated and calcium-activated currents studied in solitary rod inner segments from the salamander retina.
J Physiol (Lond)
331:253-284[Abstract/Free Full Text].
-
Begenisich T,
Lynch C
(1974)
Effects of internal divalent cations on voltage-clamped squid axons.
J Gen Physiol
63:675-689[Abstract/Free Full Text].
-
Bindokas VP,
Yoshikawa M,
Ishida AT
(1994)
Na+-Ca2+ exchanger-like immunoreactivity and regulation of intracellular Ca2+ levels in fish retinal ganglion cells.
J Neurophysiol
72:47-55[Abstract/Free Full Text].
-
Brocard JB,
Rajdev S,
Reynolds IJ
(1993)
Glutamate-induced increases in intracellular free Mg2+ in cultured cortical neurons.
Neuron
11:751-757[ISI][Medline].
-
Brooks SPJ,
Storey KB
(1992)
Bound and determined: a computer program for making buffers of defined ion concentrations.
Anal Biochem
201:119-126[ISI][Medline].
-
Burgoyne RD,
Morgan A
(1995)
Ca2+ and secretory-vesicle dynamics.
Trends Neurosci
18:191-196[ISI][Medline].
-
Callahan MJ,
Korn SJ
(1994)
Permeation of Na+ through a delayed rectifier K+ channel in chick dorsal root ganglion neurons.
J Gen Physiol
104:747-771[Abstract/Free Full Text].
-
Chang D,
Hsieh PS,
Dawson DC
(1988)
Calcium: a program in BASIC for calculating the composition of solutions with specified free concentrations of calcium, magnesium and other divalent cations.
Comput Biol Med
18:351-366[ISI][Medline].
-
Coca-Prados M,
Anguita J,
Chalfant KL,
Civan MM
(1995)
PKC-sensitive Cl
channels associated with ciliary epithelial homologue of pICln.
Am J Physiol
268:C572-C579[Abstract/Free Full Text]. -
Csermely P,
Szamel M,
Resch K,
Somogyi J
(1988)
Zinc can increase the activity of protein kinase C and contributes to its binding to plasma membranes in T lymphocytes.
J Biol Chem
263:6487-6490